Treatment by combined chemotherapy for recurrent ovarian cancer

ABSTRACT

Neoplasms of the ovary are the cause of more deaths than any other female cancer. Approximately 23% of all gynaecological cancer are of ovarian origin, but 47% of all deaths from cancer of the female genital tract are due to ovarian carcinoma. Combination systemic chemotherapy frequently produces startling remissions and yet the overall five years survival rate remains 25%, the lowest survival statistic for any major pelvic malignancy. This report describes the recurrence of a tumour nine years after extensive surgery and radiotherapy and emphasizes the importance of prolonged follow up as well as described treatment by combined chemotherapy after debulking of tumour